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eurotransmitter is released from nerve terminals
by Ca
 
2
 
 
 
-dependent exocytosis through many
steps. SNARE proteins are key components at the
priming and fusion steps, and the priming step is modu-
lated by cAMP-dependent protein kinase (PKA), which
causes synaptic plasticity. We show that the SNARE regu-
latory protein tomosyn is directly phosphorylated by PKA,
which reduces its interaction with syntaxin-1 (a compo-
nent of SNAREs) and enhances the formation of the
SNARE complex. Electrophysiological studies using cul-
tured superior cervical ganglion (SCG) neurons revealed
N
 
that this enhanced formation of the SNARE complex by
the PKA-catalyzed phosphorylation of tomosyn increased
the fusion-competent readily releasable pool of synaptic
vesicles and, thereby, enhanced neurotransmitter release.
This mechanism was indeed involved in the facilitation of
neurotransmitter release that was induced by a potent bio-
logical mediator, the pituitary adenylate cyclase-activating
polypeptide, in SCG neurons. We describe the roles and
modes of action of PKA and tomosyn in Ca
 
2
 
 
 
-dependent
neurotransmitter release.
 
Introduction
 
Synaptic vesicle exocytosis consists of many complicated
steps, such as the translocation of vesicles from the reserve
pool to the active zone, the docking of vesicles at the active
zone, transition from the docking to the priming step (forma-
tion of fusion-competent vesicles), and the fusion step (Südhof,
2000). These sequential steps involve a series of protein–protein
interactions between the membranes of synaptic vesicles and
presynaptic terminals, culminating in the Ca
 
2
 
 
 
-dependent fu-
sion of the two membranes (Südhof, 2000; Richmond and
Broadie, 2002; Rosenmund et al., 2003). Of the many proteins,
SNAREs are essential molecules in these processes (Sutton et
al., 1998; Weber et al., 1998; Weis and Scheller, 1998; Jahn
and Südhof, 1999).
Second messengers regulate protein–protein interactions
within the exocytotic machinery and, thereby, modulate neu-
rotransmitter release (Evans and Morgan, 2003). Although the
time course between action potential arrival at the nerve termi-
nal and synaptic vesicle fusion is too short for protein phosphor-
ylation/dephosphorylation to exact a direct and acute role in a
single round of vesicle exocytosis, protein kinases and phos-
phatases may have significant effects on subsequent neu-
rotransmitter release events. It is reasonable to speculate that
the phosphorylation/dephosphorylation states of synaptic pro-
teins that mediate vesicle exocytosis could regulate the bio-
chemical pathways transiting from the docking to the fusion
step. The activation of cAMP-dependent protein kinase (PKA)
is known to promote neurotransmitter release from chromaffin
cells, hippocampal mossy fiber synapses, and cerebellar parallel
fiber synapses by directly acting on the exocytotic machinery
(Lonart and Südhof, 1998; Lonart et al., 2003; Nagy et al.,
2004). Thus, it is critical to identify the PKA targets that regu-
late assembly/disassembly of the SNARE complex and the
priming of docked vesicles for the elucidation of the molecular
mechanisms underlying neurotransmitter release.
Several presynaptic proteins serve as substrates for PKA:
 
 
 
-SNAP (Hirling and Scheller, 1996), Cys string protein
(Evans et al., 2001), synapsin I (Jovanovic et al., 2001), snapin
(Chheda et al., 2001), syntaphilin (Boczan et al., 2004), RIM1
(Lonart et al., 2003), and SNAP-25 (Risinger and Bennett,
1999; Hepp et al., 2002). In chromaffin cells, two releasable
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(primed) vesicle pools (the slowly releasable pool [SRP] and
the readily releasable pool [RRP]) are functionally defined, and
their pool sizes are regulated by activation or inhibition of
PKA. The PKA-catalyzed phosphorylation of SNAP-25 influ-
ences the size of SRP, possibly by altering the rate of vesicle
priming. For example, the expression of Asp and Ala mutants
of the phosphorylation site of SNAP-25 by PKA mirrors the ef-
fects of activation and inhibition of PKA, respectively, and se-
lectively rescues the inhibitory effect of PKA inhibitors on the
size of the SRP but not that of the RRP (Nagy et al., 2004).
Therefore, for regulating RRP size, another PKA target is re-
quired. Neurons, like chromaffin cells, exhibit multiple kinetic
components of release, although overall rates are approxi-
mately 10-fold faster than that for chromaffin cells (Mennerick
and Matthews, 1996; Sakaba and Neher, 2001). Whether neu-
rons have a vesicle pool that is analogous to the SRP is not
known, but the high degree to which SNAREs are conserved
among different secretory cell types suggests that RRP may be
regulated by the phosphorylation of protein interacting with the
SNARE complex in addition to SNAP-25. However, the key
target protein for PKA remains elusive in neurons.
The upstream regulator of SNARE complex assembly,
and not just the SNAREs themselves, also could be a PKA tar-
get. We have identified a novel syntaxin-1–binding protein
named tomosyn (Fujita et al., 1998). Tomosyn is abundantly
expressed in the brain, where its distribution partly overlaps
with that of syntaxin-1 on the presynaptic plasma membrane.
Tomosyn is a 130-kD protein that contains a large NH
 
2
 
-termi-
nal domain with WD40 repeats and a COOH-terminal domain
that is homologous to vesicle-associated membrane protein
(VAMP) 2. A large NH
 
2
 
-terminal region of tomosyn shares
similarities with the 
 
Drosophila melanogaster 
 
tumor suppressor
lethal giant larvae (Lgl), its recently characterized mammalian
homologue Mlgl1, and the yeast proteins Sro7p and Sro77p
(Lehman et al., 1999; Katoh and Katoh, 2004). Recent studies
suggest that they play an important role in polarized exocytosis
by regulating SNARE function on the plasma membrane in
yeast and epithelial cells (Lehman et al., 1999; Katoh and Ka-
toh, 2004). The role of the Lgl family cannot be confined to an
activator or inhibitor of membrane fusion. We have previously
shown that tomosyn displaces Munc-18 from syntaxin-1 and
binds to the SNARE motif of syntaxin-1 via its COOH-terminal
VAMP homology region and forms a 10-S tomosyn complex
with syntaxin-1, SNAP-25, and synaptotagmin (Fujita et al.,
1998). Based on these data, we have postulated that tomosyn
plays a positive role in neurotransmission by enhancing the
availability of syntaxin-1 to form the SNARE complex (Fujita
et al., 1998). Contrary to this hypothesis, the expression of to-
mosyn results in a reduction in Ca
 
2
 
 
 
-dependent exocytosis
from PC12 cells (Fujita et al., 1998; Hatsuzawa et al., 2003).
Tomosyn interacts with the t-SNAREs syntaxin-4 and SNAP-23
and inhibits insulin-stimulated fusion of GLUT4-containing
vesicles with the plasma membrane in 3T3-L1 adipocytes
(Widberg et al., 2003). Tomosyn inhibits priming of large
dense-core vesicles in a Ca
 
2
 
 
 
-dependent manner in adre-
nal chromaffin cells (Yizhar et al., 2004). More recently, we
have shown that Rho-associated coiled-coil–forming kinase
(ROCK) that is activated by Rho small G protein phosphory-
lates syntaxin-1, which increases the affinity of syntaxin-1 for
tomosyn and forms a stable tomosyn complex. This results in
inhibition of the formation of the SNARE complex during neu-
rite extension in hippocampal cultured neurons (Sakisaka et al.,
2004). The ROCK-catalyzed phosphorylation of syntaxin-1
could act as an “on” switch for tomosyn by enhancing its inhib-
itory function on the formation of the SNARE complex. Thus,
evidence is accumulating that tomosyn acts as a negative regu-
lator for the formation of the SNARE complex, and, thereby,
inhibits various vesicle fusion events. However, an “off”
switch for tomosyn, which is the molecular regulation that
blocks its inhibitory function on the formation of the SNARE
complex, remains elusive.
In this study, we show that tomosyn is a target protein for
PKA and that the PKA-catalyzed phosphorylation of tomosyn
acts as an off switch for tomosyn. It does so by blocking its in-
hibitory function on the formation of the SNARE complex and,
thereby, up-regulating the size of readily releasable synaptic
vesicles in neurons.
 
Results
 
Phosphorylation of tomosyn by PKA in 
vitro and in vivo
 
We first examined the ability of tomosyn to serve as a substrate
for PKA in a cell-free assay system using the recombinant pro-
teins. Recombinant maltose-binding protein (MBP)–tagged
full-length tomosyn was incubated with the catalytic subunit of
PKA in the presence of 
 
 
 
-[
 
32
 
P]ATP and other necessary ingre-
dients. The reaction was terminated by adding an SDS sample
buffer and boiling, and each sample was subjected to SDS-
PAGE followed by Coomassie brilliant blue (CBB) staining.
The gel was then dried and exposed to an X-ray film to detect
the incorporation of 
 
32
 
P into tomosyn. 
 
32
 
P was incorporated into
tomosyn by PKA, and this incorporation was inhibited by pro-
tein kinase peptide inhibitor (PKI), which is a pseudosubstrate
PKA inhibitor peptide (Fig. 1 Aa). The incorporation of 
 
32
 
P
into tomosyn was time dependent, and 1 mol of phosphate was
maximally incorporated into 1 mol of tomosyn (Fig. 1 Ab).
We determined the phosphorylation site of tomosyn by
PKA using various tomosyn truncated mutants. When each puri-
fied MBP-tagged tomosyn mutant, including aa residues 1–326,
327–600, 601–800, and 801–1116, was incubated with PKA in
the presence of 
 
 
 
-[
 
32
 
P]ATP, the fragment comprising aa residues
601–800 was efficiently phosphorylated, suggesting that this
fragment contains the phosphorylation site by PKA (Fig. 1 Ba).
We conducted a sequence search against the Scansite Motif
Scanner Program, and several consensus residues for the phos-
phorylation sites by PKA were predicted in this fragment. We
focused on five Ser residues at positions 689, 693, 713, 724, and
745 and generated (by site-directed mutagenesis) tomosyn mu-
tants in which Ser at positions 689, 693, 713, 724, or 745 was re-
placed by Ala. The incorporation of 
 
32
 
P into the S724A mutant
was dramatically decreased, whereas that into other mutants was
not markedly reduced (Fig. 1 Bb), indicating that Ser-724 is at
least a major phosphorylation site of tomosyn by PKA. 
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By using Sp-cAMP and forskolin, we examined whether
tomosyn is indeed phosphorylated in intact cells in response to
cAMP. Sp-cAMP is a nonhydrolyzable and cell-permeable
cAMP analogue that induces activation of PKA in intact cells
(Scholubbers et al., 1984), whereas forskolin is a potent activator
of adenylate cyclase (Seamon et al., 1981). When 
 
32
 
Pi-labeled
NG108 cells expressing HA-tagged wild-type tomosyn (HA-
tomosyn) were stimulated by Sp-cAMP or forskolin, the in-
corporation of 
 
32
 
P into tomosyn was significantly enhanced
(Fig. 1 C). The extent of tomosyn phosphorylation that
was stimulated by Sp-cAMP and forskolin was reduced by
KT5720 and H-89, which are synthetic chemical PKA inhibi-
tors (Kase et al., 1987; Chijiwa et al., 1990). When 
 
32
 
Pi-labeled
NG108 cells expressing HA-tomosyn–S724A were stimu-
lated with Sp-cAMP, the incorporation of 
 
32
 
P into this mutant
was not markedly observed. These results indicate that tomo-
syn is directly phosphorylated by PKA both in vitro and in vivo
and that Ser-724 is the major phosphorylation site of tomosyn
by PKA.
 
Reduction by the PKA-catalyzed 
phosphorylation of tomosyn of its 
interaction with syntaxin-1 in vitro
 
We have previously shown that tomosyn interacts with syn-
taxin-1 in a manner that is competitive with VAMP-2, forms
the tomosyn complex, and down-regulates the formation of
the SNARE complex (Fujita et al., 1998; Yokoyama et al.,
1999; Sakisaka et al., 2004). We examined the effect of the
PKA-catalyzed phosphorylation of tomosyn on its interaction
with syntaxin-1 in vitro. MBP-tomosyn that was either pre-
viously phosphorylated by PKA or left unphosphorylated
was incubated with GST–syntaxin-1–bound glutathione beads.
Free MBP-tomosyn and MBP-tomosyn that bound to GST–
syntaxin-1 beads were then separated by centrifugation and
subjected to SDS-PAGE followed by CBB staining and auto-
radiography. The amount of phosphorylated MBP-tomosyn
that bound to GST–syntaxin-1 was 
 
 
 
20% of the total input,
whereas that of nonphosphorylated MBP-tomosyn was 
 
 
 
60%
of the total input (Fig. 2 A). Kinetic studies revealed that the
apparent Kd values of the phosphorylated and nonphosphory-
lated forms of GST–syntaxin-1 were 330 and 60 nM, respec-
tively (Fig. 2 B). These results indicate that the PKA-catalyzed
phosphorylation of tomosyn decreases its interaction with
syntaxin-1 in vitro.
Replacement of the Ser residue of a phosphorylation site
by a negatively charged amino acid has been shown to mimic
the effect of phosphorylation (Leger et al., 1997). We at-
tempted to mimic complete phosphorylation of Ser-724 by
mutating it to a negatively charged Asp residue (S724D) or to a
noncharged Ala residue (S724A) as a control and analyzed the
resulting activity of the mutated proteins interacting with
syntaxin-1. MBP-tomosyn, MBP-tomosyn–S724D, or MBP-
tomosyn–S724A was incubated with GST–syntaxin-1 beads,
and each tomosyn protein that bound to GST–syntaxin-1 beads
were separated by centrifugation and subjected to SDS-PAGE
followed by CBB staining. The amount of MBP-tomosyn–
Figure 1. Phosphorylation of tomosyn by
PKA in vitro and in vivo. (A) Phosphorylation of
tomosyn by PKA in a cell-free system. (Aa)
MBP-tomosyn was phosphorylated by PKA in
the absence or presence of PKI. (Ab) MBP-
tomosyn was phosphorylated by PKA for the
indicated periods of time. Gel slices containing
32P-labeled tomosyn were scintillation counted,
and the molar amount of 
32P that incorporated
into tomosyn was calculated and plotted (bot-
tom). (B) Ser-724 as the major phosphorylation
site of tomosyn. (Aa and B) After the reaction,
the reaction mixture was subjected to SDS-
PAGE followed by protein staining with CBB
and autoradiography. (Ba) Various fragments
of MBP-tomosyn were phosphorylated by PKA.
(Bb) Various mutants replacing Ser with Ala of
MBP-tomosyn (aa 601–800) were phosphory-
lated by PKA. (C) Effect of PKA activation on
the phosphorylation of tomosyn in intact cells.
NG108 cells were transfected with HA-tomo-
syn (WT) and cultured in DME for 48 h. The
cells were labeled with 
32Pi and stimulated with
or without 1 mM Sp-cAMP (Ca and Cc) or 50
 M forskolin (Cb) for 30 min in the presence
or absence of 1  M KT5720 or 2  M H-89.
The cells were lysed and immunoprecipitated
with anti-HA mAb. The immunoprecipitated
samples were subjected to SDS-PAGE followed
by protein staining with CBB and autoradiog-
raphy. The relative intensity of autoradiog-
raphy is shown in bottom panels. (Cc) Cells
were also transfected with HA-tomosyn–
S724A (S724A). The results shown are repre-
sentative of three independent experiments.
Error bars represent SEM. 
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S724D that bound to GST–syntaxin-1 was 
 
 
 
35% in comparison
with that of MBP-tomosyn, whereas that of MBP-tomosyn–
S724A was almost the same as that of MBP-tomosyn (Fig. 2 C).
These results support the aforementioned results that the PKA-
catalyzed phosphorylation of tomosyn at Ser-724 decreases its
interaction with syntaxin-1 in vitro.
 
Enhancement of the formation of the 
SNARE complex by the PKA-catalyzed 
phosphorylation of tomosyn in vivo
 
We have previously shown that the expression of tomosyn in-
creases the formation of the tomosyn complex and, thereby,
down-regulates the formation of the SNARE complex in
NG108 cells (Sakisaka et al., 2004). We examined whether the
PKA-catalyzed phosphorylation of tomosyn affects the forma-
tion of the SNARE complex. We cultured NG108 cells ex-
pressing myc-tomosyn in the presence and absence of Sp-
cAMP and immunoprecipitated syntaxin-1 from the lysate of
each NG108 cell. Both myc-tomosyn and VAMP-2 were coim-
munoprecipitated with syntaxin-1 in both cells, but the amount
of coimmunoprecipitated VAMP-2 in the cells that were pre-
treated with Sp-cAMP was more than that of control cells (Fig. 3).
Conversely, the amount of coimmunoprecipitated myc-tomo-
syn in cells that were pretreated with Sp-cAMP was less than
that of control cells. When either myc-tomosyn–S724A or
–S724D was expressed, the amount of coimmunoprecipitated
VAMP-2 in the cells expressing myc-tomosyn–S724D was
more than that in the cells expressing myc-tomosyn–S724A. In
addition, the amount of coimmunoprecipitated VAMP-2 in the
cells expressing myc-tomosyn–S724A or –S724D was not in-
creased in response to Sp-cAMP. These results are consistent
with those obtained by the in vitro experiments shown in Fig.
2 C. They indicate that the tomosyn complex was more pre-
dominantly formed in the cells expressing myc-tomosyn–
S724A than in the cells expressing myc-tomosyn–S724D and
that, conversely, the SNARE complex was less predominantly
formed in the cells expressing myc-tomosyn–S724A than in
the cells expressing myc-tomosyn–S724D. These results indi-
cate that the PKA-catalyzed phosphorylation of tomosyn de-
creases the formation of the tomosyn complex and increases
the formation of the SNARE complex in intact cells.
Figure 2. Effect of the PKA-catalyzed phosphorylation of tomosyn on its
interaction with syntaxin-1 in vitro. (A) Inhibition of the interaction of to-
mosyn with syntaxin-1 by its phosphorylation. MBP-tomosyn was first
phosphorylated by PKA in the absence or presence of  -[
32P]ATP and
was incubated with GST–syntaxin-1–bound glutathione beads followed
by centrifugation. (B) Affinities of the phosphorylated and nonphosphory-
lated forms of tomosyn for syntaxin-1. The indicated concentrations of the
nonphosphorylated or phosphorylated form of MBP-tomosyn were incu-
bated with GST–syntaxin-1–bound glutathione beads followed by centri-
fugation. (A and B) Half of the supernatant (S; A) and whole precipitated
beads (P; A and B) were solubilized and subjected to SDS-PAGE followed
by protein staining with CBB and autoradiography. (C) Mimicking the ef-
fect of the PKA-catalyzed phosphorylation of tomosyn on its interaction
with syntaxin-1 by replacing Ser (S) 724 with Asp (D). MBP-tomosyn
(WT), MBP-tomosyn–S724D (S724D), or MBP-tomosyn–S724A (S724A)
was incubated with GST–syntaxin-1–bound glutathione beads. The result-
ing complexes were subjected to SDS-PAGE followed by protein staining
with CBB. (A–C) The quantification of protein staining is shown on the right.
The results shown are representative of three independent experiments.
Error bars represent SEM.
Figure 3. Enhancement of the formation of the SNARE complex by the
PKA-catalyzed phosphorylation of tomosyn in vivo. Quantification of the
formation of tomosyn and SNARE complexes in NG108 cells. NG108
cells were transfected with myc-tomosyn (WT), myc-tomosyn–S724A
(S724A), or myc-tomosyn–S724D (S724D), cultured in DME for 48 h, and
stimulated with 1 mM Sp-cAMP for 30 min. The cells were lysed and im-
munoprecipitated with antisyntaxin-1 mAb or control mouse IgG followed
by immunoblotting with antitomosyn, antisyntaxin-1, anti–SNAP-25, or
anti–VAMP-2 pAbs. Quantifications of immunoblots are shown on the right.
The results shown are representative of three independent experiments.
Error bars represent SEM. 
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Expression and localization of tomosyn in 
SCG neurons
 
Next, we sought to investigate whether the PKA-catalyzed
phosphorylation of tomosyn is indeed involved in neurotrans-
mitter release. For this purpose, we used cultured rat superior
cervical ganglion (SCG) neurons because a potent biological
ligand for activating the endogenous PKA pathway, the pitu-
itary adenylate cyclase-activating polypeptide (PACAP), has
been shown to be a potent regulator of neurotransmitter release
from sympathetic SCG neurons (May and Braas, 1995).
PACAP belongs to the vasoactive intestinal peptide/secretin/
glucagon family of peptides, and the 185–amino acid rat pre-
cursor molecule is posttranslationally processed to two biologi-
cally active 
 
 
 
-amidated PACAP27 or 38 peptides (Miyata et
al., 1989; Arimura, 1998; Sherwood et al., 2000). PACAPs
bind to a PACAP receptor named PAC1 receptor, which is a
seven-transmembrane trimeric G protein–coupled receptor that
activates adenylate cyclase through the Gs protein subunit, re-
sulting in an elevation of cellular cAMP and the subsequent
activation of PKA (May and Braas, 1995). PAC1 receptor has
been shown to be highly expressed in sympathetic SCG neurons
(May and Braas, 1995). Before undertaking electrophysiological
assays, we first examined the expression and localization of to-
mosyn in SCG neurons. Western blotting showed that tomo-
syn as well as other SNARE proteins, including syntaxin-1,
SNAP-25, and VAMP-2, were expressed in SCG neurons at
the same levels as those in the rat cerebrum (Fig. 4 A). Immuno-
fluorescence microscopy showed that the signal for tomosyn
partly colocalized with those of syntaxin-1, synaptophysin
(synaptic vesicle marker), and Bassoon (active zone marker) at
synapses (Fig. 4 B). Tomosyn did not colocalize with the
PSD-95 family protein (postsynaptic marker). These results
indicate that tomosyn is expressed and localized at the presyn-
aptic terminals of SCG neurons.
 
Involvement of PKA in neurotransmitter 
release from SCG neurons
 
We examined whether PKA modulates neurotransmitter re-
lease from SGG neurons. For this purpose, we first examined
whether the introduction of cAMP into the presynaptic termi-
nals of SCG neurons enhances the action potential–induced
neurotransmitter release, which is measured as the amplitude of
excitatory postsynaptic potentials (EPSPs) in synaptically cou-
pled SCG neurons. Injection of cAMP (10 mM in the injection
pipette for 5 min) into the presynaptic neurons induced a long-
lasting membrane depolarization (2–5 mV for 20–30 min)
along with a modest decrease in the amplitudes of the action
potential and after hyperpolarization (Fig. 5 Aa). EPSPs that
were elicited every 20 s were increased by cAMP (Fig. 5 Ab)
with mean amplitudes up to 54 
 
 
 
 34% during the injection of
cAMP and a return to control values by 10–20 min after the in-
jection, which was followed by a further decrease below the
baseline (Fig. 5 B). Modest depolarization in the neurons, in
which cAMP was injected, was observed, but this did not seem
to affect the gating kinetics of N-type Ca
 
2
 
 
 
 channels, as de-
scribed previously (Regan et al., 1991). Consistently, PKA has
been shown not to directly modulate N-type Ca
 
2
 
 
 
 channels
(Bernheim et al., 1991; Zhu and Ikeda, 1993, 1994). Thus,
cAMP appears to directly affect the exocytotic machinery. In-
jection of a higher concentration of cAMP (50 mM in the pi-
pette) induced an increase in EPSP amplitudes, which lasted
longer (for 20–30 min) than the injection of 10 mM cAMP, al-
though the maximum increase in EPSP amplitude, 46 
 
 
 
 24%,
was not increased. These results suggest that cAMP produces
various changes in presynaptic electrical properties through the
activation of PKA and also promotes a persistent increase in
acetylcholine release from the presynaptic terminals of SCG
neurons. It should be noted that cAMP accelerated the rate of
EPSP rise but did not affect the time to reach the peak (Fig. 5
Ac), suggesting that the pool of readily releasable vesicles are
increased by the activation of PKA.
It has been proposed that PKA enhances neurotransmitter
release by increasing the size of the RRP of synaptic vesicles
(Kuromi and Kidokoro, 2000; Lonart et al., 2003; Kaneko and
Takahashi, 2004; Nagy et al., 2004) and also by increasing the
probability of fusion of synaptic vesicles (Kaneko and Taka-
hashi, 2004). We confirmed, by repetitive local applications of
Figure 4. Expression and localization of tomosyn in SCG neurons. (A)
Expression of tomosyn in SCG neurons. The homogenates of rat SCG neu-
rons at 5–6 wk in culture and rat cerebrum (25  g of protein each) were
subjected to SDS-PAGE followed by immunoblotting with antitomosyn,
antisyntaxin-1, anti–SNAP-25, or anti–VAMP-2 pAbs. (B) Localization of
tomosyn at synapses in SCG neurons. Rat SCG neurons at 5–6 wk in culture
were double stained by antitomosyn pAb and antisyntaxin-1, antisynapto-
physin, anti-Bassoon, or anti–PSD-95 family mAbs. DIC, differential interfer-
ence contrast image (cell nuclei borders are marked with dashed lines).
Insets are enlarged images of boxed areas. N, nucleus. Bars, 10  m.
The results shown are representative of three independent experiments. 
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a hypertonic solution (Rosenmund and Stevens, 1996), whether
PKA is indeed involved in the determination of RRP size. Fo-
cal puff application of 0.5 M sucrose to a synaptic pair induced
small EPSP events in postsynaptic neurons (Fig. 5 C). The inte-
gral value of small EPSPs that were induced by hypertonic
challenge reflects the size of the RRP, and, therefore, changes
in this integral value after experimental manipulation indicates
changes in the RRP size. cAMP increased the integral value by
up to 20–25%. In contrast, the release probability of synaptic
vesicles was not obviously increased by cAMP in SCG neu-
rons. Failures in postsynaptic responses after 10 presynaptic
action potentials at 5, 10, and 20 Hz in the 0.2-mM Ca
 
2
 
 
 
 exter-
nal solution was not decreased after the injection of cAMP into
the presynaptic neurons (Fig. 5 D). These results are consistent
with earlier observations in other systems (Kuromi and Ki-
dokoro, 2000; Lonart et al., 2003; Nagy et al., 2004) and suggest
that PKA up-regulates neurotransmitter release by increasing
the RRP size and does not promote a step at or downstream
of the sensing of Ca
 
2
 
 
 
, which triggers synaptic vesicle fusion at
the presynatic terminals of SCG neurons.
To further confirm that PKA is the relevant kinase medi-
ating the effect of cAMP in neurotransmitter release from SCG
neurons, we applied various reagents that modulate the PKA
signaling pathway, including forskolin, KT5720, and H-89
(Fig. 5, E–H). Forskolin enhanced neurotransmitter release,
which is consistent with the effect of cAMP (Fig. 5, E and
H). In contrast, H-89 and a combination of PKA inhibitors
(KT5720 and the PKA pseudosubstrate PKI 6–22 peptide) in-
hibited the evoked neurotransmitter release (Fig. 5, F–H).
These results indicate that PKA is the relevant kinase for regu-
lating neurotransmitter release from SCG neurons by increas-
ing the RRP size.
 
Involvement of the PKA-catalyzed 
phosphorylation of tomosyn in 
neurotransmitter release
 
To investigate the role of the PKA-catalyzed phosphorylation
of tomosyn in neurotransmitter release, we analyzed synaptic
transmission of SCG neurons by expressing myc-tomosyn,
myc-tomosyn–S724A, myc-tomosyn–S724D, or tomosyn small
interference RNA (siRNA) in the presynaptic neurons. First, we
examined electrophysiologically how many neuron pairs are
synaptically coupled. For this purpose, we recorded electrical
responses in pairs of neurons by generating action potential
trains at 2 Hz in the presynaptic neurons. The incidence of syn-
aptic coupling between control neurons (nontransfected pre-
and postsynaptic neurons) was 64 
 
 
 
 4.9% (Fig. 6 A). This
value was reduced to 40 
 
 
 
 13 and 44 
 
 
 
 6.3% by the expression
of myc-tomosyn and myc-tomosyn–S724D in the presynaptic
neurons, respectively, whereas this value was more markedly
reduced to 28 
 
 
 
 11% by the expression of myc-tomosyn–
S724A. Similarly, the incidence of synaptic coupling was re-
duced to 35 
 
 
 
 10% by expressing tomosyn siRNA, whereas the
incidence of synaptic coupling was 61 
 
 
 
 14% for control neu-
rons expressing control scramble RNA. Then, we measured the
size of EPSPs in synaptically coupled neurons. The mean EPSP
amplitude for control synapses of nontransfected neuron pairs
Figure 5. Involvement of PKA in neurotransmitter release from SCG
neurons. (A) Effects of cAMP on synaptic transmission between SCG neu-
rons. Presynaptic action potentials (Aa) and EPSPs (Ab) from one represen-
tative experiment that were recorded in a synapse before and after cAMP
injection (10 mM in the pipette for 5 min). (Ac) The first order derivative of
EPSPs shown in Ab, representing the rate of rise and fall for EPSPs. (B) 10
(top) or 50 mM cAMP (bottom) in the pipette was injected into presynaptic
neurons at time   0. Presynaptic neurons were stimulated every 20 s. (C)
The RRP size was measured by puff application of 0.5 M sucrose for 2 s
every 3 min. cAMP (50 mM in the pipette) was introduced into the presyn-
aptic neurons at time   0. Top three traces are responses to sucrose appli-
cations from one representative experiment recorded 2 min before (Cont),
4.5 min after, and 16.5 min after the start of cAMP injection. Bars, 10 mV
and 3 s. In the bottom graph, normalized and averaged integral values
for sucrose responses are plotted (n   6; *, P   0.05 at 1.5 min vs. be-
fore injection). (D) Failure of EPSPs after 10 action potentials at 20 Hz
recorded in 0.2 mM external Ca
2  solution was examined before (white
bars) and after injection of cAMP (at 50 mM in the pipette; gray bars). (E)
Effect of a PKA activator on synaptic transmission between SCG neurons.
500  M forskolin in the pipette was injected into the presynaptic neurons
for 5 min at time   0. The presynaptic neurons were stimulated every 20 s.
(F) Effect of a PKA inhibitor on synaptic transmission between SCG neu-
rons. (Fa) EPSPs from one representative experiment recorded in a syn-
apse before (control) and at 30 min after 10  M H-89 injection. (Fb) EPSP
amplitudes from one representative experiment recorded in a synapse
with the presynaptic injections of H-89. No additive reduction was pro-
duced by a second injection at a 10-fold higher concentration. (G) Effects
of other PKA inhibitors on synaptic transmission between SCG neurons.
10  M H-89 (Ga) or a mixture of 1  M PKI 6–22 and 1  M KT5720
(Gb) in the pipette was injected into the presynaptic neurons for 5 min at
time   0. The presynaptic neurons were stimulated every 20 s. (B, E, and G)
Normalized EPSP amplitudes were averaged (B and G, n   4; E, n   5)
and plotted with dots against recording time. The resulting values were
smoothed with a moving average algorithm and plotted with a line. (H)
Maximum changes in EPSP amplitudes that are shown in E and G were
averaged. Error bars represent SEM. 
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was 20 
 
 
 
 6.8 mV (Fig. 6 B). This value was reduced to 8.2 
 
 
 
2.3 and 8.1 
 
 
 
 2.4 mV by the expression of myc-tomosyn and
myc-tomosyn–S724D in the presynaptic neurons, respectively,
whereas this value was more markedly reduced to 4.8 
 
 
 
 0.7
mV by the expression of myc-tomosyn–S724A. Similarly, the
mean EPSP value was reduced to 6.7 
 
 
 
 1.7 mV by the expres-
sion of tomosyn siRNA, whereas the mean EPSP value was
21 
 
 
 
 3.2 mV for control neurons expressing control scramble
RNA. Disruption of the expression level of tomosyn in either
direction compromises neurotransmitter release. Therefore, the
expression level of tomosyn seems to be maintained at an opti-
mum level for regulating neurotransmitter release. To confirm
that the expression levels of various tomosyn mutants in SCG
neurons are similar, we immunostained SCG neurons with a to-
mosyn pAb and quantified the fluorescence intensities. The im-
munofluorescence signals for tomosyn mutants were found in
the cell body and in discrete puncta surrounding neighboring
SCG neurons, suggesting that the expressed tomosyn mutants
are translocated into the presynaptic terminals. The expression
levels of various tomosyn mutants were apparently similar (Fig.
6 C). The signal for tomosyn in the presynaptic terminals of
SCG neurons was fourfold higher than that in the presynaptic
terminals expressing the control vector. In addition, the signal
for endogenous tomosyn in the presynaptic terminals of SCG
neurons expressing tomosyn siRNA were reduced in compari-
son with that in the presynaptic terminals expressing control
scramble RNA. These results indicate that tomosyn and its phos-
phorylation by PKA are involved in neurotransmitter release
from SCG neurons.
 
Involvement of the PKA-catalyzed 
phosphorylation of tomosyn in maintaining 
a pool of readily releasable synaptic 
vesicles during repetitive stimulation
 
We examined whether the reduction of neurotransmitter release
by the expression of myc-tomosyn, myc-tomosyn–S724A, or
myc-tomosyn–S724D is caused by a depletion of synaptic ves-
icles that are primed for action potential–triggered fusion. For
this purpose, 10 action potentials were generated in presynaptic
neurons expressing myc-tomosyn, myc-tomosyn–S724A, or
myc-tomosyn–S724D, and the evoked neurotransmitter release
after each train of action potentials at varying stimulation fre-
quencies was measured (Fig. 7 A). Experiments were performed
in a low external Ca
 
2
 
 
 
 solution to avoid spike generation in the
postsynaptic neurons. Control synapses produced EPSPs after
each of 10 action potentials that were generated at 5, 10, and 20
Hz in 1.0 and 0.5 mM external Ca
 
2
 
 
 
 solutions but not in 0.2
mM external Ca
 
2
 
 
 
 solution (Fig. 7, A–Bb). In contrast, EPSP
failures were recorded in synapses between the presynaptic
neurons expressing myc-tomosyn and nontransfected postsyn-
aptic neurons even in 1.0 and 0.5 mM external Ca
 
2
 
 
 
 solutions
(Fig. 7 Bc). EPSP failure after a 20-Hz train in 0.5 mM Ca
 
2
 
 
Figure 6. Involvement of the PKA-catalyzed phosphorylation of
tomosyn in neurotransmitter release from SCG neurons. (A) Inci-
dence of synaptic coupling between the nontransfected pre- and
postsynaptic neurons (control) and between the presynaptic neu-
rons that were transfected with myc-tomosyn (WT), myc-tomo-
syn–S724A (S724A), myc-tomosyn–S724D (S724D), tomosyn
siRNA, or scramble RNA and the nontransfected postsynaptic
neurons. The incidence for each dish is averaged (n   4–9). The
bar graph shows means   SEM (*, P   0.05 vs. nontransfected
presynaptic neurons). (B) EPSPs from one representative experi-
ment recorded from the synapses between presynaptic neurons
that were transfected with the respective tomosyn expression vec-
tor and the nontransfected postsynaptic neurons. Means of EPSP
amplitudes (n   4–8; *, P   0.05 vs. presynaptic neurons that
were transfected with myc-tomosyn [WT]). (C) Expression levels
of various tomosyn mutants and the effect of tomosyn knockdown
by the RNA interference method in SCG neurons. SCG neurons
were comicroinjected with fluorescein dextran as a morphological
marker along with the same various tomosyn mutant (left) or
siRNA (right) expression vectors that were used in A and were
cultured for 40 h. The transfected cells were identified by micro-
injected fluorescein dextran (green), and the extent of expression
of various tomosyn mutants was examined by immunostaining of
tomosyn (red). The cell nuclei and plasma membrane borders of
the neighboring nontransfected postsynaptic neurons are marked
with dashed lines. N, nucleus. Arrows indicate the presynaptic
terminals. Bars, 10  m. (bottom) Quantification of relative fluo-
rescence intensities of tomosyn at the presynaptic terminal. The
results shown are representative of three independent experiments.
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was also observed in synapses between the presynaptic neurons
expressing myc-tomosyn–S724A or –S724D and the nontrans-
fected postsynaptic neurons (Fig. 7, Bd and Be). The EPSP
waveform became entangled by asynchronous responses dur-
ing trains of action potentials at 20 Hz and occasionally at 10 Hz
in synapses between the presynaptic neurons expressing myc-
tomosyn–S724A or –S724D and the nontransfected postsynaptic
neurons (Fig. 7 A). These asynchronous response profiles were
not prominent in synapses between the presynaptic neurons ex-
pressing myc-tomosyn and the nontransfected postsynaptic
neurons. Thus, neurotransmitter release from the presynaptic
neurons, in which the phosphorylation of tomosyn was pre-
vented, was not synchronized to each action potential during
high, frequent presynaptic activity. Instead, an asynchronous
mode of neurotransmitter release was induced. These results
suggest that the PKA-catalyzed phosphorylation of tomosyn is
likely to play an important role in maintaining a pool of readily
releasable synaptic vesicles that are synchronized to each action
potential during repetitive presynaptic activity.
Involvement of the PKA-catalyzed 
phosphorylation of tomosyn in 
determination of the RRP size
Next, we determined whether the PKA-catalyzed phosphoryla-
tion of tomosyn is involved in the determination of RRP size.
cAMP was injected into the presynaptic neurons expressing
myc-tomosyn, myc-tomosyn–S724A, myc-tomosyn–S724D,
or tomosyn siRNA. EPSP amplitudes were increased up to
45   18% during the injection of cAMP and persisted for  20
min in synapses between the presynaptic neurons expressing
myc-tomosyn and the nontransfected postsynaptic neurons
(Fig. 8, Aa and B). In contrast, the increase in EPSP amplitude
was significantly less in synapses between the presynaptic
neurons expressing myc-tomosyn-S724A and the nontrans-
fected postsynaptic neurons (Fig. 8, Ab and B). In synapses be-
tween presynaptic neurons expressing myc-tomosyn–S724D
and nontransfected postsynaptic neurons, EPSP amplitudes
slowly increased after the injection of cAMP (Fig. 8, Ac and B).
Apparently, the time course of enhancement of neurotransmitter
release by cAMP in the presynaptic neurons expressing myc-
tomosyn–S724D was different from that of the presynaptic
neurons expressing myc-tomosyn (Fig. 8, Aa and Ac). The in-
crease in EPSP amplitude that was caused by the injection of
cAMP was significantly blocked by the expression of tomosyn
siRNA in the presynaptic neurons (Fig. 8, Ad and B), whereas
the increase was obviously observed in synapses between the
presynaptic neurons expressing control scramble RNA and the
nontransfected postsynaptic neurons (Fig. 8 Ae). These results
suggest that PKA up-regulates neurotransmitter release via the
phosphorylation of tomosyn at S724, resulting in an increase in
the fusion-competent RRP of vesicles that are synchronized to
the arrival of action potentials.
Involvement of the PKA-catalyzed 
phosphorylation of tomosyn in the 
PACAP-induced facilitation of 
neurotransmitter release
In the last set of experiments, we investigated the physiological
significance of the PKA-catalyzed phosphorylation of tomo-
syn in neurotransmitter release from SCG neurons by using
PACAP.  Before undertaking electrophysiological assays, we
first examined the localization of PAC1 receptor in SCG neu-
rons. Immunofluorescence microscopy showed that the signal
for PAC1 receptor partly colocalized with those of tomosyn,
syntaxin-1, synaptophysin, and Bassoon at synapses (Fig. S1,
available at http://www.jcb.org/cgi/content/full/jcb.200504055/
DC1). PAC1 receptor did not colocalize with the PSD-95 family
protein. These results indicate that PAC1 receptor is expressed
and localized at the presynaptic terminals of SCG neurons.
We then examined whether the PKA-catalyzed phos-
phorylation of tomosyn is involved in the PACAP-induced fa-
cilitation of neurotransmitter release. To investigate the role
of PACAP at presynaptic terminals in SCG neurons, we fo-
cally applied PACAPs to presynaptic SCG neurons. Focal
puff application of PACAP27 or 38 (1 nM in the pipette for
0.5 s) markedly increased EPSP amplitudes and prolonged
the time course of EPSP waveforms (Fig. 9 Aa). EPSPs that
Figure 7. Involvement of the PKA-catalyzed phosphorylation of tomosyn in
maintaining a pool of readily releasable synaptic vesicles during repetitive
stimulation. EPSPs after 10 action potentials elicited in the nontransfected
presynaptic neurons (control) and the presynaptic neurons that were trans-
fected with myc control vector (vector), myc-tomosyn (WT), myc-tomosyn–
S724A (S724A), or myc-tomosyn–S724D (S724D). (A) Top trace shows
presynaptic action potentials elicited at 20 Hz. Other traces show postsyn-
aptic potentials after repetitive action potentials from one representative
experiment that was recorded in synapses between the presynaptic neu-
rons that were transfected with each tomosyn expression vector and the
nontransfected postsynaptic neurons. Electrical responses are recorded in
0.5 mM Ca
2  containing modified Krebs’ solution. *, Action potentials
are generated in the nontransfected neurons and followed by three EPSPs
overlapping with hyperpolarizations. (B) Failures of EPSPs after 10 action
potentials at 5, 10, and 20 Hz generated in the presynaptic neurons that
were transfected with the respective tomosyn expression vectors were re-
corded in 1, 0.5, and 0.2 mM external Ca
2  solutions (n   5–6; *, P  
0.05 vs. the presynaptic neurons that were transfected with myc control
vector). Error bars represent SEM.PKA-CATALYZED PHOSPHORYLATION OF TOMOSYN • BABA ET AL. 1121
were elicited every 20 s were increased by PACAP27 and 38
(Fig. 9, Ab and Ac), with the mean of peak amplitudes in-
creased to 75   27 and 66   16% of baseline control re-
sponses, respectively (Fig. 9 B). These results indicate that
low concentrations of PACAP peptides facilitate neurotrans-
mitter release, which is consistent with a previous study for
neuropeptide Y release (May and Braas, 1995). In concor-
dance with cAMP injections into the presynaptic neurons,
peptides slightly depolarized the presynaptic membrane (0–3
mV for 30–40 min; not depicted); however, this modest depo-
larization does not affect the gating kinetics of N-type Ca
2 
channels (Regan et al., 1991). Then, we examined whether
PKA is involved in the PACAP-induced facilitation of neu-
rotransmitter release by expressing a kinase-dead mutant,
PKA-K72H (Iyer et al., 2005), or a mixture of PKA catalytic
subunit (PKA C  and C ) siRNAs (Dumaz and Marais,
2003) in the presynaptic neurons. These inhibitory reagents
reduced the EPSP amplitude to 8.9   2.1 or 13   0.6 mV in
comparison with the value of 20   1.1 mV in nontransfected
neuron pairs (Fig. 9 C) and blocked the PACAP27-induced
facilitation of neurotransmitter release (Fig. 9, Da and Db).
Myc-tomosyn–S724A also reduced the PACAP27-induced
facilitation of neurotransmitter release, confirming the in-
volvement of the PKA-catalyzed phosphorylation of tomosyn
in the PACAP-induced facilitation of neurotransmitter release
(Fig. 9 Dc). The maximum increase in the mean EPSP amplitude
that was caused by PACAP27 (57   30% at 35 min after the
application) was significantly reduced by 12   18 (at 31 min;
P   0.05), 30   20 (at 30 min), and 25   8% (at 19 min) with
Figure 8. Involvement of the PKA-catalyzed phosphorylation of tomosyn
in the determination of RRP size. (A) Effects of cAMP on synaptic transmis-
sion between the presynaptic SCG neurons that were transfected with
myc-tomosyn (WT), myc-tomosyn–S724A (S724A), myc-tomosyn–S724D
(S724D), tomosyn siRNA, or scramble RNA and nontransfected postsyn-
aptic neurons. (A) cAMP was injected into the presynaptic neurons at time  
0 (50 mM in the pipette). Presynaptic neurons were stimulated every 20 s.
EPSP amplitudes were averaged (n    4–6) and plotted with dots. The
smoothed value with a moving average algorithm was plotted with a line.
(B) Bar graphs show increases in the EPSP amplitude by cAMP, which is
shown in A. Each bar shows the smoothed values of EPSP amplitudes at 10,
15, and 20 min after injection. *, P   0.05 versus presynaptic neurons that
were transfected with myc-tomosyn (WT). Error bars represent SEM.
Figure 9. Involvement of the PKA-catalyzed phosphorylation of tomosyn
in the PACAP-induced facilitation of neurotransmitter release. (A) Effects of
PACAP peptides on synaptic transmission between SCG neurons. (Aa)
EPSPs from one representative experiment recorded in a synapse before
(control) and after PACAP27 puff application (1 nM in the pipette for 0.5 s).
(Ab) 1 nM PACAP27 in the pipette was puff applied onto the presynaptic
neurons at time   0 for 0.5 s. (Ac) 1 nM PACAP38 was applied as de-
scribed in Ab. (B) Maximum increases in EPSP amplitudes were averaged
(n   4). (C) Mean amplitudes of EPSPs that were evoked by stimuli of the
presynatic neurons transfected with PKA-K72H or PKA siRNA (n   4–5; *,
P   0.05 versus nontransfected synapses). (D) Effects of PACAP27 on
EPSP amplitudes that were evoked by stimuli of the presynatic neurons
transfected with PKA-K72H, PKA siRNA, or myc-tomosyn–S724A.
PACAP27 was applied as described in Ab. (A and D) Presynaptic neurons
were stimulated every 20 s. EPSP amplitudes were averaged (n   4) and
plotted with dots. The resulting values were smoothed with a moving aver-
age algorithm and plotted with a line. (E) Maximum increases in averaged
EPSP amplitudes after PACAP27 application at 35 min after the applica-
tion for nontransfected cells, 31 min for PKA-K72H, 30 min for PKA
siRNA, and 19 min for myc-tomosyn–S724A-expressing synapses (n   4;
*, P   0.05 versus nonexpressing synapses). Error bars represent SEM.
(F) A model of a role for tomosyn in the long-lasting PACAP-induced facili-
tation of neurotransmitter release. PACAP binds to PAC1 receptor, which
is a seven-transmembrane trimeric G protein–coupled receptor that acti-
vates adenylate cyclase through the Gs protein subunit, resulting in an
elevation of cellular cAMP and subsequent activation of PKA. The PKA-
catalyzed phosphorylation of tomosyn, which is the off switch for tomo-
syn, reduces its interaction with syntaxin-1 and enhances formation of the
SNARE complex, resulting in an increase in the RRP size for the action
potential–evoked neurotransmitter release. Thus, the PKA-catalyzed
phosphorylation of tomosyn is involved in the physiological trimeric G
protein–coupled receptor’s signaling pathway and may play a role in
long-lasting synaptic modulation or plasticity. AC, adenylate cyclase.JCB • VOLUME 170 • NUMBER 7 • 2005 1122
the expression of PKA-K72H, PKA siRNA, and myc-tomosyn–
S724A, respectively (Fig. 9 E). These results suggest that
PACAP induces the facilitation of neurotransmitter release
through the PKA-catalyzed phosphorylation of tomosyn in
SCG neurons and regulates synaptic transmission efficiency
in the autonomic nervous system.
Discussion
First, we have shown in this study that tomosyn is phosphory-
lated by PKA in vitro and in vivo. The major phosphorylation
site is Ser-724, which locates in the linker region between the
NH2-terminal half WD40 repeat domain and the COOH-termi-
nal coiled-coil VAMP homology domain. We have then shown
that the PKA-catalyzed phosphorylation of tomosyn inhibits its
interaction with syntaxin-1, resulting in the enhanced forma-
tion of the SNARE complex in vivo. The COOH-terminal
coiled coil VAMP homology domain is responsible for the in-
teraction with syntaxin-1 (Yokoyama et al., 1999; Hatsuzawa
et al., 2003). Through this VAMP homology domain, tomo-
syn competes with VAMP-2 for interaction with syntaxin-1
and, thereby, prevents formation of the SNARE complex
(Yokoyama et al., 1999; Hatsuzawa et al., 2003). However, our
previous studies have shown that this VAMP homology do-
main is necessary, but not sufficient for, the high affinity inter-
action of tomosyn with syntaxin-1 (Masuda et al., 1998;
Yokoyama et al., 1999). Therefore, the linker region may make
the ternary structure of the VAMP homology domain more
sensitive to syntaxin-1. The phosphorylation of this linker re-
gion may reduce its positive effect on the VAMP homology
domain and decrease the affinity of the interaction of tomosyn
with syntaxin-1. Although further studies are necessary to elu-
cidate the molecular mechanism of the effect of the linker re-
gion, the PKA-catalyzed phosphorylation of the linker region
may act as an intramolecular off switch for tomosyn by blocking
its inhibitory effect on the formation of the SNARE complex.
Second, we have shown that the PKA-catalyzed phosphor-
ylation of tomosyn is involved in neurotransmitter release from
SCG neurons. In adrenal chromaffin cells, the PKA-catalyzed
phosphorylation of SNAP-25 has been proposed to regulate
the priming/depriming of secretory vesicles at a slow rate-
limiting step before the final fast priming step and Ca
2 -
dependent fusion (Nagy et al., 2004). Therefore, another un-
identified PKA target has been postulated to be involved in
regulation of the priming step that is associated with the quickly
releasable pool, which may control the availability of readily
releasable vesicles in nerve terminals (Heidelberger and Mat-
thews, 2004). Our results suggest that tomosyn is a candidate
PKA target for this penultimate priming step. Upon high, fre-
quent stimulation, the expression of tomosyn S724A (a mutant
that is resistant to the phosphorylation of PKA) or S724D (a
mutant mimicking the phosphorylated form of tomosyn) in-
creases the EPSP failure rate and causes the appearance of
asynchronous EPSP waveforms, suggesting that the mobiliza-
tion of readily releasable vesicles is strongly reduced when the
PKA-catalyzed phosphorylation of tomosyn Ser-724 is im-
paired. An increase in asynchronous release upon repetitive
stimulation has also been observed when the interaction of the
synprint site in N-type Ca
2  channels with the SNARE com-
plex is disrupted by synprint peptides (Mochida et al., 1996).
It is likely that preventing the formation of the SNARE com-
plex reduces its interaction with N-type Ca
2  channels that
are required for synchronous neurotransmitter release. Although
further studies are required for our understanding of the molec-
ular mechanism of vesicle priming, we propose that the PKA-
catalyzed phosphorylation of tomosyn plays an important role
in supplying readily releasable synaptic vesicles to a popula-
tion of synchronized vesicles, which are able to respond to each
action potential during repetitive presynaptic activity. Alto-
gether, our results indicate that tomosyn is a physiologically
significant PKA target that controls neurotransmitter release
through regulation of the formation of the SNARE complex
and vesicle priming.
Third, we have shown that the knockdown of tomosyn
decreases neurotransmitter release from SCG neurons, indicat-
ing that tomosyn plays both positive and negative roles in neu-
rotransmitter release. The exact reason for these apparently in-
consistent data is not known, but one explanation is that the
formation of the tomosyn complex may be a prerequisite for
the formation of the SNARE complex by analogy with the role
of Munc-18 in the formation of the SNARE complex (Gerst,
2003). Because the amount of tomosyn is less than that of syn-
taxin-1, tomosyn may catalytically facilitate the formation of
the SNARE complex. This idea requires the process in which
tomosyn is replaced by VAMP-2 to form the SNARE complex.
The PKA-catalyzed phosphorylation of tomosyn may be in-
volved in this process for releasing tomosyn form syntaxin-1
and SNAP-25. Another possible explanation is that tomosyn
affects another regulatory component besides SNAREs, such
as a cytoskeletal network, in the exocytosis of neurotransmit-
ters. Tomosyn is a member of the Lgl family (Katoh and Ka-
toh, 2004). Lgl is part of the cytoskeletal network and is associ-
ated with nonmuscle myosin II heavy chain (Strand et al.,
1994), which localizes at the presynaptic side of synaptic junc-
tions (Beach et al., 1981) and is involved in neurotransmitter
release (Mochida et al., 1994a). Recently, it was found that the
aPKC-catalyzed phosphorylation of Lgl inhibits the interaction
with myosin II and allows an autoinhibitory intramolecular in-
teraction of the NH2-terminal portion of Lgl with the COOH-
terminal portion (Betschinger et al., 2005). Similar to Lgl, to-
mosyn may interact with myosin II under the control of the
PKA-catalyzed phosphorylation of tomosyn, and this interac-
tion may be involved in the exocytosis of neurotransmitters.
Finally, we have shown the physiological significance of
the PKA-catalyzed phosphorylation of tomosyn in neurotrans-
mitter release from SCG neurons by using a potent biological
ligand to activate the endogenous PKA pathway (PACAP).
Consistent with previous studies, focally applied PACAP in-
creases EPSP amplitude along with a slight membrane depolar-
ization that is similar to the introduction of cAMP or forskolin
into the presynaptic nerve terminals of SCG neurons (May et
al., 1998; Beaudet et al., 2000). However, the effect of PACAP
lasts longer than that of cAMP or forskolin. Inhibition of the
PKA signaling pathway by the expression of kinase-deadPKA-CATALYZED PHOSPHORYLATION OF TOMOSYN • BABA ET AL. 1123
PKA-K72H or a mixture of PKA catalytic subunit (PKA
C  and C ) siRNAs significantly reduces the long-lasting
PACAP-induced facilitation of neurotransmitter release. The
expression of tomosyn-S724A (a mutant that is resistant to
the phosphorylation of PKA) also reduces the long-lasting
PACAP-induced facilitation of neurotransmitter release. The
activity of tomosyn may depend on the level of PKA activation
in the presynaptic SCG neurons. In fact, the basal level of PKA
activity varies at different synapses (Chavis et al., 1998). In the
squid giant synapse, a high resting level of PKA activity toni-
cally enhances neurotransmitter release that is elicited by sin-
gle action potentials, suggesting that the function of PKA at
this synapse is to set the initial efficacy of synaptic transmis-
sion (Hilfiker et al., 2001). In addition, PKA has been shown to
be involved in the exocytosis of various secretory systems
(Evans and Morgan, 2003). Thus, the extent of PKA-catalyzed
phosphorylation of tomosyn may modulate exocytosis not only
in SCG neurons but also in various secretory systems that un-
der the control of the physiological signaling pathway, such
as a trimeric G protein–coupled receptor’s signaling pathway
(Fig. 9 F).
We have previously shown that ROCK activated by Rho
small G protein phosphorylates syntaxin-1, which increases the
affinity of syntaxin-1 for tomosyn and forms a stable complex
with tomosyn, resulting in the inhibition of SNARE complex
formation during neurite extension (Sakisaka et al., 2004). The
ROCK-catalyzed phosphorylation of syntaxin-1 could act as an
on switch for tomosyn by enhancing its inhibitory function on
the formation of the SNARE complex. Conversely, the PKA-
catalyzed phosphorylation of tomosyn could act as an off switch
for tomosyn by blocking its inhibitory function on formation of
the SNARE complex. Although the involvement of the ROCK-
catalyzed phosphorylation of syntaxin-1 in neurotransmitter re-
lease needs to be addressed, tomosyn is an important SNARE
regulatory protein in neurotransmitter release, whose activity is
regulated via well-known signal transduction pathways.
Materials and methods
Construction of expression vectors
cDNAs encoding various fragments of rat medium-sized tomosyn (aa
1–326, 327–600, 601–800, and 801–1,116) were subcloned into
pMAL-C2 (New England Biolabs, Inc.). Tomosyn fragment (aa 601–800)
mutants, in which Ser at aa residues 689, 693, 713, 724, or 745 was re-
placed with Ala, were generated using a Site-Directed Mutagenesis Kit
(Stratagene). Expression vectors for full-length tomosyn were constructed in
pCMV-HA, pEF-BOS-myc, and pFastBac1-MBP by using standard molecu-
lar biology methods. pFastBac1-MBP was constructed with a baculovirus
transfer vector, pFastBac1 (Invitrogen), to express a fusion protein with
NH2-terminal MBP (Yasumi et al., 2005). Full-length tomosyn mutants, in
which Ser at aa residue 724 was replaced with Ala or Asp, were gener-
ated using the Site-Directed Mutagenesis Kit. cDNA encoding PKA C 
was subcloned into pEF-BOS-myc. PKA C  mutants, in which Lys at aa res-
idue 72 was replaced with His, were also generated using a Site-Directed
Mutagenesis Kit (Iyer et al., 2005).
Abs
The antitomosyn pAb was prepared as described previously (Fujita et al.,
1998). The antisyntaxin-1 mAb, anti–VAMP-2 pAb (Synaptic Systems
GmbH), antisyntaxin-1 pAb, anti–SNAP-25 pAb (Calbiochem), antisynap-
tophysin mAb (Chemicon), anti-Bassoon mAb (StressGen Biotechnologies),
anti–PSD-95 family mAb (Upstate Biotechnology), anti-PACAP receptor
pAb (Santa Cruz Biotechnology, Inc.), and anti-HA mAb (Babco) were
purchased from commercial sources. AlexaFluor-conjugated secondary
Abs (Invitrogen) were used to detect primary Abs in immunofluorescence
microscopy of SCG neurons.
Phosphorylation of tomosyn by PKA in a cell-free system
Phosphorylation of tomosyn was performed in 50  l of a reaction mixture
containing 50 mM Tris-HCl, pH 7.5, 7 mM MgCl2, 1 mM DTT, 0.06%
CHAPS, 1 mM EDTA, 50  M  -[
32P]ATP (0.5–1.2   10
3 cpm/pmol; GE
Healthcare), and 25 units of the catalytic subunit of PKA (Promega) at
30 C in the presence or absence of 2 mM pseudosubstrate PKI (Promega).
The reaction was stopped by the addition of SDS sample buffer and was
boiled for 5 min. Each sample was subjected to SDS-PAGE followed by
protein staining with CBB and autoradiography. Relevant gel slices were
excised, and scintillation was counted to determine the radioactivity that
incorporated into tomosyn.
Phosphorylation of tomosyn in intact cells
NG108 cells were transfected with either pCMV-HA-tomosyn or pCMV-
HA-tomosyn-S724A and cultured in DME containing HT (0.10 mM hypo-
xanthine and 0.16 mM thymidine; Sigma-Aldrich) for 48 h. The cells were
washed three times with phosphate-free DME and incubated for 30 min in
phosphate-free DME containing HT. Thereafter, the cells were prelabeled
with 0.3 mCi/ml [
32P]orthophosphate (phosphorus-32; GE Healthcare) for
3 h. The cells were preincubated with or without 1  M KT5720 (Calbio-
chem) or 2  M H-89 (Calbiochem) for 30 min and further stimulated by
1.0 mM Sp-cAMP (Sigma-Aldrich) or 50  M forskolin (Calbiochem) for
30 min. The cells were lysed with radioimmunoprotein assay buffer (20
mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% SDS, 1% Triton X-100, 1%
deoxycholate, and 5 mM EDTA) and immunoprecipitated with anti-HA
mAb. The immunoprecipitates were subjected to SDS-PAGE followed by
protein staining with CBB and autoradiography.
Assay for the interaction of tomosyn with syntaxin-1
40 pmol MBP-tomosyn was fully phosphorylated by 25 units of the catalytic
subunit of PKA. Phosphorylated tomosyn was incubated with 30 pmol GST–
syntaxin-1 that was bound to 10  l glutathione beads in the presence of
1% CHAPS at 4 C for 30 min followed by centrifugation and extensive
washing. As a control, 40 pmol MBP-tomosyn was incubated under the
same conditions as described above except that  -[
32P]ATP was excluded.
The intensity of the bands in SDS-PAGE was determined by densitometry.
Assay for the formation of tomosyn and SNARE complexes
The lysate of NG108 cells was prepared by using a lysis buffer (20 mM
Hepes-NaOH, pH 7.4, 90 mM KOAc, 2 mM Mg(OAc)2, 0.5 mM EGTA,
50 mM NaF, 2 mM Na3VO4, and 1% CHAPS; Fujita et al., 1998). The
lysates were incubated with an antisyntaxin-1 mAb at 4 C for 2 h. The
immune complexes were precipitated with protein G–Sepharose beads
(GE Healthcare) at 4 C for 1 h, washed with the lysis buffer, resolved in
5–20% gradient SDS-PAGE, and analyzed by immunoblotting with anti-
tomosyn, anti–VAMP-2, anti–SNAP-25, and antisyntaxin-1 pAbs.
Culture of SCG neurons
Postnatal day 7 Wistar ST rats were decapitated under diethylether anes-
thesia according to Physiological Society of Japan guidelines. Isolated
SCG neurons were maintained in culture for 5–6 wk as described previ-
ously (Mochida et al., 1994b; Mochida, 1995). In brief, SCGs were dis-
sected, desheathed, and incubated with 0.5 mg/ml collagenase (Wor-
thington Biochemical) in L-15 (GIBCO BRL) at 37 C for 10 min. After
enzyme digestion, the semidissociated ganglion was triturated gently
through a small pore glass pipette until a cloudy suspension was ob-
served. After washing by low speed centrifugation at 1,300 rpm for 3 min,
the collected cells were plated onto coverslips in plastic dishes (Corning;
35-mm diameter; approximately one ganglion per dish) containing a
growth medium of 84% MEM (GIBCO BRL), 10% FCS (GIBCO BRL), 5%
horse serum (GIBCO BRL), 1% penicillin/streptomycin (GIBCO BRL), and
25 ng/ml nerve growth factor (2.5 S; grade II; Alomone Laboratories).
The cells were maintained at 37
oC in a 95% air/5% CO2 humidified incu-
bator, and the medium was changed twice per week.
Immunocytochemistry
SCG neurons were fixed with 4% PFA for 30 min or acetone for 5 min.
After washing with PBS, the cells were permeabilized with 0.25% Triton
X-100 in PBS for 5 min. Nonspecific binding was blocked with Block Ace
(Dainippon Pharmaceutical) for 2 h. The cells were incubated with pri-
mary Abs that were diluted in Block Ace for 1.5 h followed by secondary
Abs. The stained cells were observed with a confocal laser microscopeJCB • VOLUME 170 • NUMBER 7 • 2005 1124
(Radiance 2000; Bio-Rad Laboratories) using a 63  oil immersion objec-
tive lens (model LSM510; Carl Zeiss MicroImaging, Inc.). Collected data
were exported as eight-bit TIFF files and were processed using Adobe
Photoshop 7.0.
Expression and knockdown of PKA or tomosyn in SCG neurons
The mammalian expression vector pBS-H1 (Yamada et al., 2005) was
used for the expression of siRNA. The following inserts were used: the PKA
C  gene–specific insert was a 21-nucleotide sequence corresponding to
nt 885–905 (5 -AAGTGGTTTGCCACAACTGAC-3 ) of PKA C  cDNA,
and the PKA C  gene–specific insert was nt 25–45 (5 -AAGAGTTC-
CTAGCCAAAGCCA-3 ) of PKA C  cDNA, which was separated by a
10-nucleotide noncomplementary spacer (5 -TTGATATCCG-3 ) from the
reverse complement of the same 21-nucleotide sequence (Dumaz and Ma-
rais, 2003). An expression vector for tomosyn siRNA was constructed
(Sakisaka et al., 2004). Various tomosyn or PKA expression vectors and
the tomosyn or PKA siRNA expression vector were microinjected into the
nuclei of SCG neurons through a microglass pipette along with 10 kD flu-
orescein dextran (Invitrogen) as described previously (Mochida et al.,
2003). Entry of the constructs into the cell was monitored by fluorescence
intensity in the nucleus or that of the dye in the cell body. The cells were
maintained at 37 C in a 95% air/5% CO2 humified incubator for 40–70 h,
and the injected neurons were identified with an inverted microscope
(Diaphot 300; Nikon) equipped with an epifluorescence unit and a fluo-
rescence microscope system (Arugas/HiSCA; Hamamatsu Photonics).
The injected neurons were examined as the presynaptic neurons in paired
neuronal recordings.
Synaptic transmission between SCG neurons
EPSPs were recorded as described previously (Mochida et al., 1994a).
Conventional intracellular recordings were made from two neighboring
neurons by using microelectrodes filled with 1 M KAc (70–90 M ). EPSPs
were recorded from a nontransfected neuron, whereas action potentials
were generated in the transfected neuron with various tomosyn expression
vectors or the tomosyn siRNA expression vector by the passage of current
through an intracellular recording electrode. Synaptic couples with sub-
threshold EPSPs that did not produce postsynaptic action potentials were
selected for further study. Neurons were superfused with a modified
Krebs’ solution consisting of 136 mM NaCl, 5.9 mM KCl, 2.5 mM CaCl2,
1.2 mM MgCl2, 11 mM glucose, and 3 mM Na-Hepes, pH 7.4, except
for recordings of EPSPs with 10 stimuli, which were superfused in a Krebs’
solution containing 0.2, 0.5, and 1 mM CaCl2. Electrophysiological data
were collected and analyzed by using software written by the late L. Tauc
(Centre National de la Recherche Scientifique, Gif-sur-Yvette, France; Mo-
chida et al., 1996) and analyzed with Origin 7.0 software (Microcal Soft-
ware). The peak amplitudes of EPSPs were averaged, and the resulting
values were smoothed by an eight-point moving average algorithm and
plotted against recording time with time   0 indicating the start of the pre-
synaptic injection of cAMP (Sigma-Aldrich), forskolin, H-89, a mixture of
PKI 6–22 (Calbiochem) and KT5720, or the start of puff application of
PACAP27 and 38 (Sigma-Aldrich). Reagents for injection were dissolved
in 150 mM KAc, 5 mM Mg
2 -ATP, and 10 mM Hepes, pH 7.3, and were
introduced into the presynaptic cell body by diffusion from a suction glass
pipette (15–20-M  tip resistance). 5% Fast Green FCF (Sigma-Aldrich)
was included via the peptide injection solution to confirm entry into the pre-
synaptic cell body. The injection pipette was removed 5 or 10 min after
starting injection. To measure RRP size, 0.5 M sucrose was puff applied to
presynaptic neurons every 3 min (Mochida et al., 1998). Each sucrose re-
sponse was recorded with Clampex, and the integral values that were
measured by Fetchan (pClamp 8.1; Axon Instruments, Inc.) were aver-
aged and normalized. Each experiment was performed in a minimum of
four synaptically coupled SCG neuron pairs. Data values with associated
error are shown in the text, and figures represent means   SEM. A two-
tailed t test was applied to compare effects among presynaptic neurons
that were transfected with various tomosyn expression vectors or between
the presynaptic neurons that were transfected with tomosyn siRNA and
those transfected with scramble RNA.
Online supplemental material
Fig. S1 shows the localization of PACAP receptor in SCG neurons. Online
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200504055/DC1.
We thank T. Manabe (Tokyo University, Tokyo, Japan) and M. Kano
(Kanazawa University, Kanazawa, Japan) for comments on the manuscript. 
This work was supported by grants-in-aid for scientific research (to S.
Mochida) and cancer research (to Y. Takai) from the Ministry of Education,
Culture, Sports, Science, and Technology of Japan (2004). T. Sakisaka is
a recipient of a Human Frontier Science Program Career Development
Award (2003).
Submitted: 11 April 2005
Accepted: 22 August 2005
References
Arimura, A. 1998. Perspectives on pituitary adenylate cyclase activating
polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous
systems. Jpn. J. Physiol. 48:301–331.
Beach, R.L., P.T. Kelly, J.A. Babitch, and C.W. Cotman. 1981. Identification of
myosin in isolated synaptic junctions. Brain Res. 225:75–93.
Beaudet, M.M., R.L. Parsons, K.M. Braas, and V. May. 2000. Mechanisms me-
diating pituitary adenylate cyclase-activating polypeptide depolarization
of rat sympathetic neurons. J. Neurosci. 20:7353–7361.
Bernheim, L., D.J. Beech, and B. Hille. 1991. A diffusible second messenger
mediates one of the pathways coupling receptors to calcium channels in
rat sympathetic neurons. Neuron. 6:859–867.
Betschinger, J., F. Eisenhaber, and J.A. Knoblich. 2005. Phosphorylation-
induced autoinhibition regulates the cytoskeletal protein Lethal (2) giant
larvae. Curr. Biol. 15:276–282.
Boczan, J., A.G. Leenders, and Z.H. Sheng. 2004. Phosphorylation of syntaphi-
lin by cAMP-dependent protein kinase modulates its interaction with
syntaxin-1 and annuls its inhibitory effect on vesicle exocytosis. J. Biol.
Chem. 279:18911–18919.
Chavis, P., P. Mollard, J. Bockaert, and O. Manzoni. 1998. Visualization of
cyclic AMP-regulated presynaptic activity at cerebellar granule cells.
Neuron. 20:773–781.
Chheda, M.G., U. Ashery, P. Thakur, J. Rettig, and Z.H. Sheng. 2001. Phos-
phorylation of Snapin by PKA modulates its interaction with the SNARE
complex. Nat. Cell Biol. 3:331–338.
Chijiwa, T., A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K.
Naito, T. Toshioka, and H. Hidaka. 1990. Inhibition of forskolin-induced
neurite outgrowth and protein phosphorylation by a newly synthesized
selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bro-
mocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D
pheochromocytoma cells. J. Biol. Chem. 265:5267–5272.
Dumaz, N., and R. Marais. 2003. Protein kinase A blocks Raf-1 activity by stim-
ulating 14-3-3 binding and blocking Raf-1 interaction with Ras. J. Biol.
Chem. 278:29819–29823.
Evans, G.J., and A. Morgan. 2003. Regulation of the exocytotic machinery by
cAMP-dependent protein kinase: implications for presynaptic plasticity.
Biochem. Soc. Trans. 31:824–827.
Evans, G.J., M.C. Wilkinson, M.E. Graham, K.M. Turner, L.H. Chamberlain,
R.D. Burgoyne, and A. Morgan. 2001. Phosphorylation of cysteine
string protein by protein kinase A. Implications for the modulation of
exocytosis. J. Biol. Chem. 276:47877–47885.
Fujita, Y., H. Shirataki, T. Sakisaka, T. Asakura, T. Ohya, H. Kotani, S.
Yokoyama, H. Nishioka, Y. Matsuura, A. Mizoguchi, et al. 1998. Tomo-
syn: a syntaxin-1-binding protein that forms a novel complex in the neu-
rotransmitter release process. Neuron. 20:905–915.
Gerst, J.E. 2003. SNARE regulators: matchmakers and matchbreakers. Biochim.
Biophys. Acta. 1641:99–110.
Hatsuzawa, K., T. Lang, D. Fasshauer, D. Bruns, and R. Jahn. 2003. The
R-SNARE motif of tomosyn forms SNARE core complexes with syn-
taxin 1 and SNAP-25 and down-regulates exocytosis. J. Biol. Chem.
278:31159–31166.
Heidelberger, R., and G. Matthews. 2004. Vesicle priming and depriming: a
SNAP decision. Neuron. 41:311–313.
Hepp, R., J.P. Cabaniols, and P.A. Roche. 2002. Differential phosphorylation of
SNAP-25 in vivo by protein kinase C and protein kinase A. FEBS Lett.
532:52–56.
Hilfiker, S., A.J. Czernik, P. Greengard, and G.J. Augustine. 2001. Tonically ac-
tive protein kinase A regulates neurotransmitter release at thesquid giant
synapse. J. Physiol. 531:141–146.
Hirling, H., and R.H. Scheller. 1996. Phosphorylation of synaptic vesicle pro-
teins: modulation of the alpha SNAP interaction with the core complex.
Proc. Natl. Acad. Sci. USA. 93:11945–11949.
Iyer, G.H., M.J. Moore, and S.S. Taylor. 2005. Consequences of lysine 72 mu-
tation on the phosphorylation and activation state of cAMP-dependent
kinase. J. Biol. Chem. 280:8800–8807.
Jahn, R., and T.C. Südhof. 1999. Membrane fusion and exocytosis. Annu. Rev.
Biochem. 68:863–911.PKA-CATALYZED PHOSPHORYLATION OF TOMOSYN • BABA ET AL. 1125
Jovanovic, J.N., T.S. Sihra, A.C. Nairn, H.C. Hemmings, P. Greengard, and
A.J. Czernik. 2001. Opposing changes in phosphorylation of specific
sites in synapsin I during Ca
2 -dependent glutamate release in isolated
nerve terminals. J. Neurosci. 21:7944–7953.
Kaneko, M., and T. Takahashi. 2004. Presynaptic mechanism underlying
cAMP-dependent synaptic potentiation. J. Neurosci. 24:5202–5208.
Kase, H., K. Iwahashi, S. Nakanishi, Y. Matsuda, K. Yamada, M. Takahashi, C.
Murakata, A. Sato, and M. Kaneko. 1987. K-252 compounds, novel and
potent inhibitors of protein kinase C and cyclic nucleotide-dependent
protein kinases. Biochem. Biophys. Res. Commun. 142:436–440.
Katoh, M., and M. Katoh. 2004. Identification and characterization of human
LLGL4 gene and mouse Llgl4 gene in silico. Int. J. Oncol. 24:737–742.
Kuromi, H., and Y. Kidokoro. 2000. Tetanic stimulation recruits vesicles from
reserve pool via a cAMP-mediated process in Drosophila  synapses.
Neuron. 27:133–143.
Leger, J., M. Kempf, G. Lee, and R. Brandt. 1997. Conversion of serine to aspar-
tate imitates phosphorylation-induced changes in the structure and func-
tion of microtubule-associated protein tau. J. Biol. Chem. 272:8441–8446.
Lehman, K., G. Rossi, J.E. Adamo, and P. Brennwald. 1999. Yeast homologues of
tomosyn and lethal giant larvae function in exocytosis and are associated
with the plasma membrane SNARE, Sec9. J. Cell Biol. 146:125–140.
Lonart, G., and T.C. Südhof. 1998. Region-specific phosphorylation of rab-
philin in mossy fiber nerve terminals of the hippocampus. J. Neurosci.
18:634–640.
Lonart, G., S. Schoch, P.S. Kaeser, C.J. Larkin, T.C. Südhof, and J.D. Linden.
2003. Phosphorylation of RIM1alpha by PKA triggers presynaptic long-
term potentiation at cerebellar parallel fiber synapses. Cell. 115:49–60.
Masuda, E.S., B.C. Huang, J.M. Fisher, Y. Luo, and R.H. Scheller. 1998. Tomo-
syn binds t-SNARE proteins via a VAMP-like coiled coil. Neuron. 21:
479–480.
May, V., and K.M. Braas. 1995. Pituitary adenylate cyclase-activating polypep-
tide (PACAP) regulation of sympathetic neuron neuropeptide Y and cat-
echolamine expression. J. Neurochem. 65:978–987.
May, V., M.M. Beaudet, R.L. Parsons, J.C. Hardwick, E.A. Gauthier, J.P.
Durda, and K.M. Braas. 1998. Mechanisms of pituitary adenylate cy-
clase activating polypeptide (PACAP)-induced depolarization of sym-
pathetic superior cervical ganglion (SCG) neurons. Ann. NY Acad. Sci.
865:164–175.
Mennerick, S., and G. Matthews. 1996. Ultrafast exocytosis elicited by cal-
cium current in synaptic terminals of retinal bipolar neurons. Neuron.
17:1241–1249.
Miyata, A., A. Arimura, R.R. Dahl, N. Minamino, A. Uehara, L. Jiang, M.D.
Culler, and D.H. Coy. 1989. Isolation of a novel 38 residue-hypotha-
lamic polypeptide which stimulates adenylate cyclase in pituitary cells.
Biochem. Biophys. Res. Commun. 164:567–574.
Mochida, S. 1995. Role of myosin in neurotransmitter release: functional studies
at synapses formed in culture. J. Physiol. (Paris). 89:83–94.
Mochida, S., H. Kobayashi, Y. Matsuda, Y. Yuda, K. Muramoto, and Y. Nono-
mura. 1994a. Myosin II is involved in transmitter release at synapses
formed between rat sympathetic neurons in culture. Neuron. 13:1131–
1142.
Mochida, S., Y. Nonomura, and H. Kobayashi. 1994b. Analysis of the mecha-
nism for acetylcholine release at the synapse formed between rat sympa-
thetic neurons in culture. Microsc. Res. Tech. 29:94–102.
Mochida, S., Z.H. Sheng, C. Baker, H. Kobayashi, and W.A. Catterall. 1996. In-
hibition of neurotransmission by peptides containing the synaptic protein
interaction site of N-type Ca
2  channels. Neuron. 17:781–788.
Mochida, S., C.T. Yokoyama, D.K. Kim, K. Itoh, and W.A. Catterall. 1998. Ev-
idence for a voltage-dependent enhancement of neurotransmitter release
mediated via the synaptic protein interaction site of N-type Ca
2  chan-
nels. Proc. Natl. Acad. Sci. USA. 95:14523–14528.
Mochida, S., R.E. Westenbroek, C.T. Yokoyama, K. Itoh, and W.A. Catterall.
2003. Subtype-selective reconstitution of synaptic transmission in sym-
pathetic ganglion neurons by expression of exogenous calcium channels.
Proc. Natl. Acad. Sci. USA. 100:2819–2824.
Nagy, G., K. Reim, U. Matti, N. Brose, T. Binz, J. Rettig, E. Neher, and J.B. So-
rensen. 2004. Regulation of releasable vesicle pool sizes by protein ki-
nase A-dependent phosphorylation of SNAP-25. Neuron. 41:417–429.
Regan, L.J., D.W. Sah, and B.P. Bean. 1991. Ca
2  channels in rat central and
peripheral neurons: high-threshold current resistant to dihydropyridine
blockers and omega-conotoxin. Neuron. 6:269–280.
Richmond, J.E., and K.S. Broadie. 2002. The synaptic vesicle cycle: exocytosis
and endocytosis in Drosophila and C. elegans. Curr. Opin. Neurobiol.
12:499–507.
Risinger, C., and M.K. Bennett. 1999. Differential phosphorylation of syntaxin
and synaptosome-associated protein of 25 kDa (SNAP-25) isoforms.
J. Neurochem. 72:614–624.
Rosenmund, C., and C.F. Stevens. 1996. Definition of the readily releasable
pool of vesicles at hippocampal synapses. Neuron. 16:1197–1207.
Rosenmund, C., J. Rettig, and N. Brose. 2003. Molecular mechanisms of active
zone function. Curr. Opin. Neurobiol. 13:509–519.
Sakaba, T., and E. Neher. 2001. Preferential potentiation of fast-releasing syn-
aptic vesicles by cAMP at the calyx of Held. Proc. Natl. Acad. Sci. USA.
98:331–336.
Sakisaka, T., T. Baba, S. Tanaka, G. Izumi, M. Yasumi, and Y. Takai. 2004.
Regulation of SNAREs by tomosyn and ROCK: implication in extension
and retraction of neurites. J. Cell Biol. 166:17–25.
Scholubbers, H.G., P.H. van Knippenberg, J. Baraniak, W.J. Stec, M. Morr, and
B. Jastorff. 1984. Investigations on stimulation of lac transcription in
vivo in Escherichia coli by cAMP analogues. Biological activities and
structure-activity correlations. Eur. J. Biochem. 138:101–109.
Seamon, K.B., W. Padgett, and J.W. Daly. 1981. Forskolin: unique diterpene
activator of adenylate cyclase in membranes and in intact cells. Proc.
Natl. Acad. Sci. USA. 78:3363–3367.
Sherwood, N.M., S.L. Krueckl, and J.E. McRory. 2000. The origin and function
of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glu-
cagon superfamily. Endocr. Rev. 21:619–670.
Strand, D., R. Jakobs, G. Merdes, B. Neumann, A. Kalmes, H.W. Heid, I. Hus-
mann, and B.M. Mechler. 1994. The Drosophila lethal (2) giant larvae
tumor suppressor protein forms homo-oligomers and is associated with
nonmuscle myosin II heavy chain. J. Cell Biol. 127:1361–1373.
Südhof, T.C. 2000. The synaptic vesicle cycle revisited. Neuron. 28:317–320.
Sutton, R.B., D. Fasshauer, R. Jahn, and A.T. Brunger. 1998. Crystal structure
of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution.
Nature. 395:347–353.
Weber, T., B.V. Zemelman, J.A. McNew, B. Westermann, M. Gmachl, F. Par-
lati, T.H. Sollner, and J.E. Rothman. 1998. SNAREpins: minimal ma-
chinery for membrane fusion. Cell. 92:759–772.
Weis, W.I., and R.H. Scheller. 1998. Membrane fusion. SNARE the rod, coil
the complex. Nature. 395:328–329.
Widberg, C.H., N.J. Bryant, M. Girotti, S. Rea, and D.E. James. 2003. Tomosyn
interacts with the t-SNAREs syntaxin4 and SNAP23 and plays a role in in-
sulin-stimulated GLUT4 translocation. J. Biol. Chem. 278:35093–35101.
Yamada, A., K. Irie, T. Hirota, T. Ooshio, A. Fukuhara, and Y. Takai. 2005. In-
volvement of the annexin II-S100A10 complex in the formation of
E-cadherin-based adherens junctions in Madin-Darby canine kidney
cells. J. Biol. Chem. 280:6016–6027.
Yasumi, M., T. Sakisaka, T. Hoshino, T. Kimura, Y. Sakamoto, T. Yamanaka,
S. Ohno, and Y. Takai. 2005. Direct binding of Lgl2 to LGN during
mitosis and its requirement for normal cell division. J. Biol. Chem.
280:6761–6765.
Yizhar, O., U. Matti, R. Melamed, Y. Hagalili, D. Bruns, J. Rettig, and U. Ash-
ery. 2004. Tomosyn inhibits priming of large dense-core vesicles in a
calcium-dependent manner. Proc. Natl. Acad. Sci. USA. 101:2578–2583.
Yokoyama, S., H. Shirataki, T. Sakisaka, and Y. Takai. 1999. Three splicing
variants of tomosyn and identification of their syntaxin-binding region.
Biochem. Biophys. Res. Commun. 256:218–222.
Zhu, Y., and S.R. Ikeda. 1993. 2,3-butanedione monoxime blockade of Ca
2 
currents in adult rat sympathetic neurons does not involve ‘chemical
phosphatase’ activity. Neurosci. Lett. 155:24–28.
Zhu, Y., and S.R. Ikeda. 1994. VIP inhibits N-type Ca
2  channels of sympa-
thetic neurons via a pertussis toxin-insensitive but cholera toxin-sensi-
tive pathway. Neuron. 13:657–669.